Diagnostyka SA (DIAP)

Currency in PLN
202.50
-1.30(-0.64%)
Closed·
DIAP Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
DIAP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
201.70205.90
52 wk Range
122.80209.00
Key Statistics
Bid/Ask
202.50 / 203.60
Prev. Close
203.8
Open
205.9
Day's Range
201.7-205.9
52 wk Range
122.8-209
Volume
22.92K
Average Volume (3m)
57.34K
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
190.80
Downside
-5.78%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with low price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Diagnostyka SA Company Profile

Diagnostyka S.A. operates as a medical laboratory. The company was founded in 1998 and is based in Krakow, Poland.

Employees
7836
Market
Poland

Compare DIAP to Peers and Sector

Metrics to compare
DIAP
Peers
Sector
Relationship
P/E Ratio
29.9x20.6x−0.6x
PEG Ratio
-0.720.00
Price/Book
14.1x2.0x2.6x
Price / LTM Sales
3.4x1.0x3.3x
Upside (Analyst Target)
−4.7%16.8%39.1%
Fair Value Upside
Unlock13.6%5.4%Unlock

Analyst Ratings

5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 190.80
(-5.78% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.87%
Dividend Yield
1.62%
Industry Median 1.90%
Annualised payout
3.31
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 27, 2025
EPS / Forecast
2.16 / --
Revenue / Forecast
591.55M / --
EPS Revisions
Last 90 days

DIAP Income Statement

People Also Watch

77.00
XTB
+1.93%
77.78
PKN
-0.51%
226.40
SNTP
-1.22%
45.43
DNP
+0.73%
454.70
KRU
+0.26%

FAQ

What Stock Exchange Does Diagnostyka Trade On?

Diagnostyka is listed and trades on the Warsaw Stock Exchange stock exchange.

What Is the Stock Symbol for Diagnostyka?

The stock symbol for Diagnostyka is "DIAP."

What Is the Diagnostyka Market Cap?

As of today, Diagnostyka market cap is 6.86B.

What Is Diagnostyka's Earnings Per Share (TTM)?

The Diagnostyka EPS (TTM) is 6.87.

When Is the Next Diagnostyka Earnings Date?

Diagnostyka will release its next earnings report on 17 Sept 2025.

From a Technical Analysis Perspective, Is DIAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Diagnostyka Stock Split?

Diagnostyka has split 0 times.

How Many Employees Does Diagnostyka Have?

Diagnostyka has 7836 employees.

What is the current trading status of Diagnostyka (DIAP)?

As of 29 Aug 2025, Diagnostyka (DIAP) is trading at a price of 202.50, with a previous close of 203.80. The stock has fluctuated within a day range of 201.70 to 205.90, while its 52-week range spans from 122.80 to 209.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.